Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines

Autor: Emilie Mérour, Ronan N. Rouxel, Stéphane Biacchesi, Michel Brémont
Přispěvatelé: Unité de recherche Virologie et Immunologie Moléculaires (VIM), Institut National de la Recherche Agronomique (INRA), ABIVAX France, Unité de recherche Virologie et Immunologie Moléculaires (VIM (UR 0892)), Moriya Tsuji, Bremont-Deletang, Michel
Rok vydání: 2016
Předmět:
RNA viruses
0301 basic medicine
Influenza Viruses
Viral Diseases
Physiology
[SDV]Life Sciences [q-bio]
viruses
lcsh:Medicine
Pathology and Laboratory Medicine
medicine.disease_cause
Biochemistry
Madin Darby Canine Kidney Cells
Mice
Immunologic Adjuvants
Influenza A Virus
H1N1 Subtype

Immune Physiology
Medicine and Health Sciences
Influenza A virus
Public and Occupational Health
Fluorescent Antibody Technique
Indirect

lcsh:Science
Mononegavirales
Mice
Inbred BALB C

Vaccines
Synthetic

Vaccines
Novirhabdovirus
Immune System Proteins
Multidisciplinary
biology
Viral Vaccine
Vaccination
Animal Models
Vaccination and Immunization
Recombinant Proteins
3. Good health
Hemagglutinins
Infectious Diseases
Medical Microbiology
Viral Pathogens
Viruses
Female
Pathogens
Plasmids
Research Article
Carps
Infectious hematopoietic necrosis virus
Immunology
Hemagglutinin (influenza)
Mouse Models
Research and Analysis Methods
Microbiology
Antibodies
Virus
Cell Line
03 medical and health sciences
Dogs
Model Organisms
Orthomyxoviridae Infections
medicine
Animals
Antigens
Microbial Pathogens
Biology and life sciences
lcsh:R
Organisms
Proteins
biology.organism_classification
Antibodies
Neutralizing

Virology
Influenza
Microscopy
Electron

030104 developmental biology
13. Climate action
biology.protein
lcsh:Q
Viral hemorrhagic septicemia
Preventive Medicine
Orthomyxoviruses
Zdroj: PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (10), pp.1-17. ⟨10.1371/journal.pone.0164245⟩
Plos One 10 (11), 1-17. (2016)
PLoS ONE, Vol 11, Iss 10, p e0164245 (2016)
ISSN: 1932-6203
Popis: Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20 degrees C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.
Databáze: OpenAIRE